Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Cash from Operations (2023 - 2024)

Exozymes (EXOZ) has disclosed Cash from Operations for 2 consecutive years, with 5707527.0 as the latest value for Q4 2024.

  • Quarterly Cash from Operations fell 628.67% to 5707527.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 8505650.0 through Dec 2024, changed N/A year-over-year, with the annual reading at 6502040.0 for FY2025, 23.56% up from the prior year.
  • Cash from Operations for Q4 2024 was 5707527.0 at Exozymes, down from 541524.0 in the prior quarter.
  • The five-year high for Cash from Operations was 281199.0 in Q1 2024, with the low at 5707527.0 in Q4 2024.